The rising interest in copyright , specifically the B974 formulation at 30mg, presents considerable difficulties within AU . While Dexamphetamine is unavailable accessible through official channels in Australia , reports suggest its emergence on the copyright. This absence of authorized distribution fuels concerns surrounding likely diversion, unau